Loading
A phase 1 trial of ST-1898 run by AccSalus Biosciences, Inc., not yet recruiting.
Study of ACC-1898 in Adult Participants With Advanced Solid Tumors is a phase 1 interventional study registered as NCT07252661 by AccSalus Biosciences, Inc., with 40 participants planned, started 2027-01. Conditions recorded: Hepatocellular Carcinoma, Renal Cell Carcinoma, Thyroid Carcinoma, Medullary, Thyroid Carcinoma Primary Differentiated, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Melanoma, Gall Bladder Cancer and Advanced Solid Tumor. Interventions recorded: ACC-1898.
Shares Beijing Scitech-Mq Pharmaceuticals, ST-1898, Thyroid cancer and the tag pipeline.
Shares Beijing Scitech-Mq Pharmaceuticals, ST-1898, Renal cell carcinoma and the tag pipeline.
Shares Beijing Scitech-Mq Pharmaceuticals, ST-1898, Melanoma and the tag pipeline.
Shares Thyroid cancer, Renal cell carcinoma, Hepatocellular carcinoma, Gastric & gastro-oesophageal junction cancer and the tag pipeline.
Shares Renal cell carcinoma, Hepatocellular carcinoma, Gastric & gastro-oesophageal junction cancer, Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Renal cell carcinoma, Gastric & gastro-oesophageal junction cancer, Melanoma, Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Hepatocellular carcinoma, Melanoma, Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Renal cell carcinoma, Hepatocellular carcinoma, Metastatic cancer (cancer that has spread) and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/